Juan Jaen
Founder at ARCUS BIOSCIENCES, INC.
Net worth: 29 M $ as of 31/03/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Terry Rosen | M | 65 |
Flexus Biosciences, Inc.
 Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA.
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA.
University of Michigan
| 36 years |
| Robert Bradway | M | 61 | 18 years | |
| Steve Young | M | 55 |
Flexus Biosciences, Inc.
Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA.
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 23 years |
| David Goeddel | M | 72 |
Flexus Biosciences, Inc.
Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA.
Hexagon Bio, Inc.
 Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | 12 years |
| Kathryn Falberg | F | 63 | 14 years | |
| Andrew J. Perlman | M | 76 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 16 years |
| José Mejía Oneto | M | - |
Shasqi, Inc.
 Shasqi, Inc. Pharmaceuticals: MajorHealth Technology Shasqi, Inc. operates as a biopharmaceutical company. It develops novel chemistry to optimize the healing power of modern medicine. The company was founded by Jose M. Mejia Oneto and is headquartered in San Francisco, CA. | - |
| Yasunori Kaneko | M | 69 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 16 years |
| Robert Goeltz | M | 51 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 7 years |
| Colin James Bell Harvey | M | - |
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | - |
| Maureen E. Hillenmeyer | M | - |
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | - |
| Jennifer Jarrett | F | 53 | 7 years | |
| Robert Eckert | M | 69 | 21 years | |
| Clarence Machado | M | 60 | 5 years | |
| Yvonne Gehring | F | - | 16 years | |
| Alexander Azoy | M | 48 | 4 years | |
| Nicole Lambert | F | 50 | 3 years | |
| Matthew Busch | M | 50 | 20 years | |
| David Lacey | M | 71 | 4 years | |
| Brian T. Naughton | M | - |
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | - |
| Antoni Ribas | M | 57 | 5 years | |
| David Reese | M | 61 | 19 years | |
| Jonathan Edwards | M | 40 |
Breakpoint Therapeutics GmbH
 Breakpoint Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breakpoint Therapeutics GmbH engages in the discovery and development of anti-cancer drugs. It aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways. The company is headquartered in Hamburg, Germany. | - |
| Eric Matthews | M | - | 5 years | |
| Holli Kolkey | M | - | - | |
| Millie Ray | M | - |
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | - |
| Jonathan Hollick | M | - |
Breakpoint Therapeutics GmbH
Breakpoint Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breakpoint Therapeutics GmbH engages in the discovery and development of anti-cancer drugs. It aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways. The company is headquartered in Hamburg, Germany. | 5 years |
| Daniel Speidel | M | - |
Breakpoint Therapeutics GmbH
Breakpoint Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breakpoint Therapeutics GmbH engages in the discovery and development of anti-cancer drugs. It aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways. The company is headquartered in Hamburg, Germany. | 5 years |
| Cord Dohrmann | M | 60 |
Breakpoint Therapeutics GmbH
Breakpoint Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breakpoint Therapeutics GmbH engages in the discovery and development of anti-cancer drugs. It aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways. The company is headquartered in Hamburg, Germany. | - |
| Carolyn Tang | F | 45 | 7 years | |
| Dimitry Nuyten | M | - | 2 years | |
| Derek Miller | M | - | 21 years | |
| Mike Zahigian | M | - | 23 years | |
| Johanna Mercier | F | 54 | - | |
| Alex Kolich | M | - |
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | - |
| Linda Higgins | M | 62 | 3 years | |
| Merdad Parsey | M | 61 | 4 years | |
| Jonathan Yingling | M | 55 | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David W. Beier | M | 75 | 10 years | |
| William Rieflin | M | 64 |
Flexus Biosciences, Inc.
Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA.
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 8 years |
| Jason Barker | M | 54 | 1 years | |
| Steven McKnight | M | 75 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 13 years |
| Madhavan Balachandran | M | 73 | 20 years | |
| Paul Eisenberg | M | - | 14 years | |
| Usama Mohammad Fayyad | M | 60 |
University of Michigan
| 11 years |
| Michael Kelly | M | 67 | 14 years | |
| David M. di Rita | M | - |
University of Michigan
| 7 years |
| Leonard Schaeffer | M | 78 | 9 years | |
| Sean E. Harper | M | 61 | 16 years | |
| John Moriarty | M | 56 | 6 years | |
| Wael Gad | M | - |
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ. | - |
| Haluk Dinçer | M | 62 |
University of Michigan
| 6 years |
| James Daly | M | 63 | 9 years | |
| Hui Tian | M | - |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 9 years |
| Diana McKenzie | F | 59 | 12 years | |
| Michael Severino | M | 58 | 10 years | |
| Katherine A. Lauer | F | - |
University of Michigan
| 7 years |
| Daniel Flynn | M | 70 |
Warner-Lambert Co.
Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ. | - |
| Vasant Prakash Gandhi | M | - | 5 years | |
| Craig Shepherd | M | - | 7 years | |
| Karl R. Fink | M | - |
University of Michigan
| 7 years |
| Thomas Zindrick | M | 65 | 8 years | |
| Willard Dere | M | 70 | 11 years | |
| Susan Lundeen Smuck | F | 57 | 12 years | |
| Patricia A. Turney | F | 57 | 23 years | |
| Lawrence Wieser | M | - |
University of Michigan
| 6 years |
| Alex Horvitz | M | - |
University of Michigan
| 5 years |
| Rachel Lenington | F | 51 | 10 years | |
| Carla Daniel | F | - |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 6 years |
| Geoffrey Parker | M | 59 | 13 years | |
| Gil Syswerda | M | - |
University of Michigan
| 5 years |
| William Ashton | M | 73 | 16 years | |
| Lodewijk J. R. de Vink | M | 78 |
Warner-Lambert Co.
Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ. | 12 years |
| Jerry D. Choate | M | 86 | - | |
| David J. Scott | M | 71 | - | |
| Glenn P. Barba | M | 58 |
University of Michigan
| 5 years |
| Brian M. McNamee | M | 67 | - | |
| Daniel Hamburger | M | 60 |
University of Michigan
| 5 years |
| Michael A. Sosin | M | 64 |
University of Michigan
| 8 years |
| Joseph Feczko | M | 75 | 10 years | |
| Ira Klein | M | 61 | 2 years | |
| Frank Herringer | M | 81 | 15 years | |
| Frederick Gluck | M | 88 | 13 years | |
| David Baltimore | M | 86 | 21 years | |
| J. Reason | M | 83 | 12 years | |
| William P. Sheridan | M | 69 | 5 years | |
| Mike Sayama | M | 69 |
University of Michigan
| 4 years |
| James Tyree | M | 71 | 10 years | |
| Andrew B. Bressler | M | - |
University of Michigan
| 5 years |
| Bob Casale | M | 65 |
Warner-Lambert Co.
Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ. | - |
| Martin Simonetti | M | 66 | 7 years | |
| Barbara L. Silkworth | F | - |
University of Michigan
| 5 years |
| Jeffery M. Brinza | M | 62 |
Warner-Lambert Co.
Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.
University of Michigan
| 12 years |
| Jeffrey S. Geiger | M | 62 |
University of Michigan
| 5 years |
| Jin Long Chen | M | 61 | 4 years | |
| Guru Kothandaraman | M | - |
University of Michigan
| 5 years |
| Frank J. Biondi | M | 79 | 15 years | |
| Cynthia Flowers | F | 64 | 5 years | |
| Sahijdak Walter | M | - |
University of Michigan
| 32 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 95 | 95.96% |
| Germany | 4 | 4.04% |
| United Kingdom | 0 | -.--% |
| Spain | 0 | -.--% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Juan Jaen
- Personal Network